| Name | Title | Contact Details |
|---|
Invio Automation is a prominent provider of custom automation solutions, focusing on designing, building, and integrating advanced systems for high-growth industries. The company serves sectors such as Medical Device & Life Sciences, Renewable Energy, Mobility, Logistics & Fulfillment, and Industrial. With over 65 years of experience, Invio is headquartered in Hudson, NH, and operates seven production sites across North America. The team at Invio consists of hundreds of engineers and skilled professionals dedicated to delivering large-scale automation projects. Their offerings include robotic automation services, development of Autonomous Mobile Robots (AMRs), and a range of specialized solutions such as thermal bonding and precision dispensing. Invio also provides consulting and R&D services to help clients prepare for future automation needs. The company collaborates with a diverse customer base, supporting operations of all sizes across various industries.
Bienvenido a Citibanamex. Un espacio en donde cada paso cuenta para iniciar una nueva relación con tu dinero y en donde impulsamos a la transformación de nuestra comunidad y colaboradores. Conoce la información financiera más importante.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Qualitas is a full-service consulting firm dedicated to quality results for our clients. We provide expert advice and technical support for business processes and tools, especially Contract Lifecycle Management (CLM) and Enterprise Legal Management (ELM) solutions. We are passionate about helping our clients achieve long‑lasting success, and we are proud to be a woman-owned business.
Tasty Restaurant Group LLC (TRG) is based in Dallas, Texas, and focuses on operating and expanding a portfolio of popular restaurant brands. As an affiliate of Triton Pacific Capital Partners, TRG emphasizes the importance of strong teams in delivering exceptional service and quality to guests, which is vital for the success of its brands. The company provides operational and managerial support to its restaurants, concentrating on talent development, guest experiences, and community engagement. TRG operates a diverse range of franchised restaurants, including well-known names like Pizza Hut, Burger King, Dunkin, Baskin-Robbins, Kentucky Fried Chicken (KFC), and Taco Bell. With a presence in at least 21 states, TRG aims to improve existing locations and expand through strategic acquisitions, supported by a leadership team with extensive experience in the restaurant industry.